Option chain shows key data for Fresenius SE & Co's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Fresenius SE & Co.

Fresenius SE & Co (OTC:FSNUF) Stock, Option Chain

Fresenius SE is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.

Equities

Large Cap

News

Health Care

Media

General

FSNUF

U.S. Senator Amy Klobuchar has called on HHS Secretary Xavier Becerra to address the national IV solution shortage following the closure of Baxter&#39;s facility due to Hurricane Helene, which compromises patient care and poses risks of price gouging.

Baxter&#39;s North Carolina Facility Manufactures ~60% Of IV Fluids And Peritoneal Dialysis Solutions, Senator Demands Immediate Action To Protect Patient Care Amid Shortage

Rumors

Movers

DANOY

YHOO

Benzinga&#39;s Weekend M&amp;A Chatter

FRESENIUS SE & CO by Fresenius SE & Co. KGaA

Fresenius SE & Co KGaA

Fresenius SE & Co. KGaA (FSNUF) Q2 2024 Earnings Call Transcript

My Dividend Stock Portfolio: New July Dividend Record - 101 Holdings With 24 Buys

Fresenius: Showing Signs Of Recovery, We Have Dawn

Undercovered Dozen: KinderCare Learning, Xeris Biopharma, Generac, Philips +

My Dividend Stock Portfolio: New September Dividend Record - 100 Holdings With 12 Buys

Fresenius SE & Co. reports Q3 results

Fresenius SE & Co. KGaA (FSNUF) Q3 2024 Earnings Call Transcript

DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation

My Dividend Stock Portfolio: New November Dividend Record - 97 Holdings With 18 Buys

Fresenius: The Signs Of A Significant Turnaround Are Getting Clearer And Clearer

Comments

Fresenius SE & Co

Fresenius SE & Co (FSNUF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga